Mr John Erb, page-32

SSH can repay the $8 million to access an extra $8 million and more time to raise or partner , I think SSH have a few irons in the fire that is better placed if FDA gave expedited path to approval and NUB 1 for a stronger negotiation point or subject to the above happening extra funding or grant will follow .
SSH would have a big problem if CP1 and CP2 Data was bad , Data results are excellent, the problem is only money , this uncertainty will be resolved very soon, I would like to hear John Erb say something .